Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.

MLA

Bouisset, Frederic, et al. “Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.” JAMA Cardiology, vol. 8, no. 7, July 2023, pp. 703–08. EBSCOhost, https://doi.org/10.1001/jamacardio.2023.1373.

APA

Bouisset, F., Sia, J., Mizukami, T., Karjalainen, P. P., Tonino, P. A. L., Pijls, N. H. J., Van der Heyden, J., Romppanen, H., Kervinen, K., Airaksinen, J. K. E., Lalmand, J., Frambach, P., Roza da Costa, B., Collet, C., & De Bruyne, B. (2023). Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial. JAMA Cardiology, 8(7), 703–708. https://doi.org/10.1001/jamacardio.2023.1373

Chicago

Bouisset, Frederic, Jussi Sia, Takuya Mizukami, Pasi P Karjalainen, Pim A L Tonino, Nico H J Pijls, Jan Van der Heyden, et al. 2023. “Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.” JAMA Cardiology 8 (7): 703–8. doi:10.1001/jamacardio.2023.1373.